DavidRRubinowMD
Psychiatry • Chapel Hill, NCProfessor and Chair of Psychiatry; Professor of Medicine; Director, UNC Innovation and Health Care System Transformation; and Director, UNC Center for Women’s Mood Disorders
Dr. Rubinow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
304 Macnider Hall Cb 7160
Chapel Hill, NC 27599- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterResidency, Psychiatry, 1979 - 1981
Yale-New Haven Medical CenterResidency, Psychiatry, 1976 - 1979
Uconn School Of MedicineClass of 1975
Certifications & Licensure
NC State Medical License 2006 - 2024
MD State Medical License 1980 - 2007
DC State Medical License 1982 - 2006- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2011
Clinical Trials
- Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 1 citationsEffects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality.Jordan C Barone, Elizabeth Wenzel, Viraja Alluri, Daniel Moriarity, Graziano Pinna, Erin Walsh, David R Rubinow, A Leslie Morrow, Tory A Eisenlohr-Moul> ;Psychoneuroendocrinology. 2023 Nov 1
- 2 citationsGABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder.Christopher Sikes-Keilp, David R Rubinow> ;CNS Drugs. 2023 Aug 1
- 2 citationsTemporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition.Tory Eisenlohr-Moul, Danielle A Swales, David R Rubinow, Lauren Schiff, Crystal E Schiller> ;Neuropsychopharmacology. 2024 Jan 1
- Join now to see all
Journal Articles
- Safety of Estradiol Treatment in Perimenopausal Asymptomatic Women—ReplyDavid Rubinow, MD, JAMA
- Sex Differences and the Neurobiology of Affective DisordersDavid Rubinow, MD, Nature
Authored Content
- Progesterone and Plasma Metabolites in Women with and in Those Without Premenstrual Dysphoric DisorderSeptember 2018
- Progesterone and Plasma Metabolites in Women with and in Those Without Premenstrual Dysphoric DisorderSeptember 2018
- F122. The Neuronal Stem Cell Transcriptome of Premenstrual Dysphoric DisorderApril 2018
- S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018
- S102. Pilot Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Major Depressive DisorderApril 2018
- Join now to see all
Press Mentions
FDA Approves ZULRESSO™ (Brexanolone) Injection for Postpartum Depression Following Three Clinical Trials Led by UNC ResearcherMarch 20th, 2019
Brain Stimulation Improves Depression Symptoms, Restores Brain Waves in Clinical StudyMarch 11th, 2019
Study Shows How Neuroactive Steroids Inhibit Activity of Pro-Inflammatory ProteinsFebruary 14th, 2019- Join now to see all
Grant Support
- Depression, Estrogen Replacement, And Cardiovascular Health In The PerimenopauseNational Institute Of Mental Health2010–2012
- Continuous OC Treatment In PMDD: Steroid Hormone MechanismsNational Institute Of Mental Health2008–2011
- Menstrually Related Mood Disorders Screening ProtocolNational Center For Research Resources2008
- Sex Dimorphisms/Gonadal Steroid Effect--NeuroregulationNational Institute Of Mental Health2005
- Reproductive Endocrine Related Mood DisordersNational Institute Of Mental Health2003–2005
- Neuroregulation: Sexual Dimorphisms And Gonadal SteroidsNational Institute Of Mental Health2004
- Reproductive Endocrine Related Mood Disorders--DifferentNational Institute Of Mental Health2001–2004
- Sexual Dimorphisms &Gonadal Steroid Effects On NeuroregNational Institute Of Mental Health2001–2003
- Sexual Dimorphisms &Gonadal Steroid Effects On Neuroregulation/NeurodevelopmentNational Institute Of Mental Health1997–2000
- Reproductive Endocrine Related Mood Disorders--Differential SensitivityNational Institute Of Mental Health1997–2000
- Sexual Dimorphisms &Amp;Gonadal Steroid Effects On Neuroregulation/NeurodevelopmNational Institute Of Mental Health1998
- Psychobiology And Treatment Of Menstrually Related Mood DisordersNational Institute Of Mental Health1997
- Psychobiology And Treatment Of Menstrually-Related Mood DisordersNational Institute Of Mental Health1996
- Psychobiology And Treatment Of Peri-Menopausal Mood DisordersNational Institute Of Mental Health1991–1995
- Psychobiology And Treatment Of Peri-Menopausal DisordersNational Institute Of Mental Health1990
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
